Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-01-01 @ 7:13 AM
Study NCT ID:
NCT05007132
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2021-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Sponsor:
Dominik Paul Modest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2029-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-12
First Submit QC Date:
None
Study First Post Date:
2021-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-14
Last Update Post Date:
2024-02-15
Last Update Post Date Type:
ACTUAL